帕金森病多胺代谢谱:有前景的生物标志物
该研究通过两个队列的血浆代谢组分析,评估多胺代谢物作为帕金森病(PD)年龄相关、诊断及严重程度相关生物标志物的能力。结果显示,N1,N8-二乙酰精胺具有最高诊断价值并与H&Y分期、UPDRS-III及轴突退化相关;精胺合成及N1,N8-二乙酰精胺可能分别作为诊断和严重程度相关的生物标志物。
要点
- N1,N8-二乙酰精胺对PD诊断价值最高,且与疾病严重程度和轴突退化相关。
- PD患者精胺水平和精胺/亚精胺比值显著降低,伴随多胺乙酰化增强。
- 精胺在SH-SY5Y等细胞系中是最强的自噬诱导剂。
核心结论
- 精胺合成和N1,N8-二乙酰精胺可能分别作为PD的诊断和严重程度相关生物标志物。
研究设计与样本
- 研究分为队列A(对照45例,PD 145例)进行血浆综合代谢组分析,以及队列B(对照49例,PD 186例,进行性核上性麻痹19例,阿尔茨海默病23例)分析7种多胺代谢物。
- 队列B中20例PD患者接受了弥散张量成像(DTI)检查,并在多种细胞系中体外检测多胺代谢物的自噬诱导能力。
主要发现
- 队列A中,PD患者N8-乙酰亚精胺和N-乙酰腐胺水平分别显著且轻度升高。
- 队列B中,PD患者精胺水平和精胺/亚精胺比值显著降低,伴随多胺乙酰化增强。
- N1,N8-二乙酰精胺水平具有最高诊断价值,并与H&Y分期、UPDRS-III及DTI量化的轴突退化相关。
- 对照组的精胺/亚精胺比值随年龄下降,但在PD中持续受抑制。
- 精胺是所测多胺代谢物中最强的自噬诱导剂,尤其在SH-SY5Y细胞中。
关键数值与推荐
- PD患者精胺水平和精胺/亚精胺比值显著降低。
- N1,N8-二乙酰精胺具有最高诊断价值,并与H&Y分期、UPDRS-III和DTI量化的轴突退化相关。
临床怎么用
- N1,N8-二乙酰精胺可能作为PD诊断及严重程度评估的候选生物标志物。
- 精胺/亚精胺比值随年龄变化且在PD中持续抑制,可能有助于年龄相关诊断。
局限性
- 未发现与精胺/亚精胺代谢相关的5个基因编码酶的显著遗传变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aging is the highest risk factor for Parkinson disease (PD). Under physiological conditions, spermidine and spermine experimentally enhance longevity via autophagy induction. Accordingly, we evaluated the ability of each polyamine metabolite to act as an age-related, diagnostic, and severity-associated PD biomarker. METHODS: Comprehensive metabolome analysis of plasma was performed in Cohort A (controls, n = 45; PD, n = 145), followed by analysis of 7 polyamine metabolites in Cohort B (controls, n = 49; PD, n = 186; progressive supranuclear palsy, n = 19; Alzheimer disease, n = 23). Furthermore, 20 patients with PD who were successively examined within Cohort B were studied using diffusion tensor imaging (DTI). Association of each polyamine metabolite with disease severity was assessed according to Hoehn and Yahr stage (H&Y) and Unified Parkinson's Disease Rating Scale motor section (UPDRS-III). Additionally, the autophagy induction ability of each polyamine metabolite was examined in vitro in various cell lines. RESULTS: In Cohort A, N8-acetylspermidine and N-acetylputrescine levels were significantly and mildly elevated in PD, respectively. In Cohort B, spermine levels and spermine/spermidine ratio were significantly reduced in PD, concomitant with hyperacetylation. Furthermore, N1,N8-diacetylspermidine levels had the highest diagnostic value, and correlated with H&Y, UPDRS-III, and axonal degeneration quantified by DTI. The spermine/spermidine ratio in controls declined with age, but was consistently suppressed in PD. Among polyamine metabolites, spermine was the strongest autophagy inducer, especially in SH-SY5Y cells. No significant genetic variations in 5 genes encoding enzymes associated with spermine/spermidine metabolism were detected compared with controls. INTERPRETATION: Spermine synthesis and N1,N8-diacetylspermidine may respectively be useful diagnostic and severity-associated biomarkers for PD. ANN NEUROL 2019;86:251-263.
引用
- Saiki S, Sasazawa Y, Fujimaki M, et al. A metabolic profile of polyamines in parkinson disease: A promising biomarker. Ann Neurol. 2019. PMID: 31155745. doi:10.1002/ana.25516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。